These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 11112059
1. Prolonged survival of baboon renal allografts using idarubicin-conjugated anti-CD4 monoclonal antibodies. Botha JF, Tandon V, Linley W, Mall A, Davison G, Shephard E, McKenzie IF, Kahn D. Transpl Int; 2000; 13 Suppl 1():S480-1. PubMed ID: 11112059 [Abstract] [Full Text] [Related]
4. CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog. Watson CJ, Cobbold SP, Davies HS, Rebello PR, Waldmann H, Calne RY, Metcalfe SM. Br J Surg; 1993 Nov; 80(11):1389-92. PubMed ID: 8252344 [Abstract] [Full Text] [Related]
5. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K, Arima T, Lehmann M, Flye MW. Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [Abstract] [Full Text] [Related]
6. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K, Arima T, Yu S, Lehmann M, Flye MW. Transplantation; 2000 Jan 27; 69(2):285-93. PubMed ID: 10670640 [Abstract] [Full Text] [Related]
7. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T, Lehmann M, Flye MW. Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332 [Abstract] [Full Text] [Related]
8. Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies. Watson CJ, Cobbold SP, Davies HS, Rebello PR, Thiru S, McNair R, Rasmussen A, Waldmann H, Calne RY, Metcalfe SM. Tissue Antigens; 1994 Mar 27; 43(3):155-62. PubMed ID: 7916496 [Abstract] [Full Text] [Related]
9. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons. Boulday G, Ashton-Chess J, Bernard P, Karam G, Vié H, Moreau A, Minault D, Lorré K, Soulillou JP, Blancho G. Nephrol Dial Transplant; 2004 Jul 27; 19(7):1752-60. PubMed ID: 15069178 [Abstract] [Full Text] [Related]
10. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Shizuru JA, Seydel KB, Flavin TF, Wu AP, Kong CC, Hoyt EG, Fujimoto N, Billingham ME, Starnes VA, Fathman CG. Transplantation; 1990 Sep 27; 50(3):366-73. PubMed ID: 1976282 [Abstract] [Full Text] [Related]
11. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice. Mottram PL, Han WR, Murray-Segal LJ, Mandel TE, Pietersz GA, McKenzie IF. Transplantation; 1997 Sep 15; 64(5):684-90. PubMed ID: 9311703 [Abstract] [Full Text] [Related]
12. Survival, function, morphology and serological aspects of rat renal allografts. Effect of short-term treatment with cyclosporine A, anti-CD4 and anti-interleukin-2 receptor monoclonal antibodies. Steinbrüchel DA, Larsen S, Kristensen T, Starklint H, Koch C, Kemp E. APMIS; 1992 Aug 15; 100(8):682-94. PubMed ID: 1520480 [Abstract] [Full Text] [Related]
13. CD4 and CD8 monoclonal antibody therapy in canine renal allografts. Watson CJ, Cobbold SP, Davies HF, Rebello PR, Waldmann H, Calne RY, Metcalfe SM. Transpl Int; 1994 Aug 15; 7 Suppl 1():S322-4. PubMed ID: 11271241 [Abstract] [Full Text] [Related]
14. Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids. Fechner JH, Dong Y, Hong X, Brunner KG, Tsuchida M, Neville D, Scharff J, Lee F, Oberley TD, Peters D, Schultz JM, Manthei ER, Hamawy MM, Knechtle SJ. Transplantation; 2001 Aug 27; 72(4):581-7. PubMed ID: 11544415 [Abstract] [Full Text] [Related]
15. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Yin DP, Sankary HN, Talor-Edwards C, Chong AS, Foster P, Shen J, Ma LL, Williams JW, Fathman CG. Transplantation; 1998 Jul 15; 66(1):1-5. PubMed ID: 9679814 [Abstract] [Full Text] [Related]
16. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice. Song HK, Alters SE, Fathman CG. Transplantation; 1993 Jan 15; 55(1):133-9. PubMed ID: 8420037 [Abstract] [Full Text] [Related]
17. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group. Transplantation; 1997 May 15; 63(9):1243-51. PubMed ID: 9158016 [Abstract] [Full Text] [Related]